XML 51 R39.htm IDEA: XBRL DOCUMENT v3.22.2
Investments in Nuclear Decommissioning Trusts and Other Special Use Funds (Tables)
 6 Months Ended
Jun. 30, 2022
Investments, Debt and Equity Securities [Abstract]  
Fair value of APS's nuclear decommissioning trust fund assets
The following tables present the unrealized gains and losses based on the original cost of the investment and summarizes the fair value of APS’s nuclear decommissioning trusts and other special use fund assets (dollars in thousands):  
June 30, 2022
 Fair ValueTotal
Unrealized
Gains		Total
Unrealized
Losses
Investment Type:Nuclear Decommissioning TrustsOther Special Use FundsTotal
Equity securities$473,392 $29,093 $502,485 $327,032 $(183)
Available for sale-fixed income securities601,295 316,375 917,670 (a)2,997 (56,826)
Other1,401 938 2,339 (b)— — 
Total$1,076,088 $346,406 $1,422,494 $330,029 $(57,009)

(a)As of June 30, 2022, the amortized cost basis of these available-for-sale investments is $971 million.
(b)Represents net pending securities sales and purchases.

December 31, 2021
 Fair ValueTotal
Unrealized
Gains		Total
Unrealized
Losses
Investment Type:Nuclear Decommissioning TrustsOther Special Use FundsTotal
Equity securities$640,312 $47,570 $687,882 $451,387 $— 
Available for sale-fixed income securities682,227 309,904 992,131 (a)24,283 (4,063)
Other(27,782)936 (26,846)(b)— — 
Total$1,294,757 $358,410 $1,653,167 $475,670 $(4,063)

(a)As of December 31, 2021, the amortized cost basis of these available-for-sale investments is $972 million.
(b)Represents net pending securities sales and purchases.
Realized gains and losses and proceeds from the sale of securities by the nuclear decommissioning trust funds
The following tables set forth APS’s realized gains and losses relating to the sale and maturity of available-for-sale debt securities and equity securities, and the proceeds from the sale and maturity of these investment securities (dollars in thousands):
 Three Months Ended June 30,
 Nuclear Decommissioning TrustsOther Special Use FundsTotal
2022
Realized gains$6,282 $— $6,282 
Realized losses(12,439)— (12,439)
Proceeds from the sale of securities (a)309,966 20,466 330,432 
2021
Realized gains$1,406 $— $1,406 
Realized losses(1,146)— (1,146)
Proceeds from the sale of securities (a)190,340 17,524 207,864 

(a)    Proceeds are reinvested in the nuclear decommissioning trusts and other special use funds, excluding amounts reimbursed to the Company for active union employee medical claims from the active union employee medical account.

 Six Months Ended June 30,
 Nuclear Decommissioning TrustsOther Special Use FundsTotal
2022
Realized gains$7,305 $— $7,305 
Realized losses(19,674)— (19,674)
Proceeds from the sale of securities (a)629,659 62,011 691,670 
2021
Realized gains$4,374 $— $4,374 
Realized losses(5,294)— (5,294)
Proceeds from the sale of securities (a)425,068 162,774 587,842 

(a)    Proceeds are reinvested in the nuclear decommissioning trusts and other special use funds, excluding amounts reimbursed to the Company for active union employee medical claims from the active union employee medical account.
Fair value of fixed income securities, summarized by contractual maturities
The fair value of APS’s fixed income securities, summarized by contractual maturities, at June 30, 2022, is as follows (dollars in thousands):
 Nuclear Decommissioning TrustsCoal Reclamation Escrow AccountActive Union Employee Medical AccountTotal
Less than one year$13,114 $47,528 $40,224 $100,866 
1 year – 5 years192,566 31,422 150,008 373,996 
5 years – 10 years127,287 — 43,023 170,310 
Greater than 10 years268,328 4,170 — 272,498 
Total$601,295 $83,120 $233,255 $917,670